.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Teva
Deloitte
Argus Health
Daiichi Sankyo
Cipla
McKesson
Fuji
Medtronic
Queensland Health

Generated: February 20, 2018

DrugPatentWatch Database Preview

Patents Expiring in 2027

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Theravance BiopharmaVIBATIVtelavancin hydrochloridePOWDER;IV (INFUSION)022110-002Sep 11, 2009RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
Theravance BiopharmaVIBATIVtelavancin hydrochloridePOWDER;IV (INFUSION)022110-001Sep 11, 2009DISCNYesNo➤ Try a Free Trial➤ Try a Free TrialY
Luitpold Pharms IncINJECTAFERferric carboxymaltoseINJECTABLE;INTRAVENOUS203565-001Jul 25, 2013RXYesYes➤ Try a Free Trial➤ Try a Free TrialYMETHOD OF TREATMENT OF IRON-RELATED CONDITIONS WITH AT LEAST 0.6 GRAMS OF ELEMENTAL IRON VIA AN IRON CARBOHYDRATE COMPLEX, WITH A SUBSTANTIALLY NON-IMMUNOGENIC CARBOHYDRATE COMPONENT, IN ABOUT 15 MINUTES OR LESS.
Novartis Pharms CorpZYKADIAceritinibCAPSULE;ORAL205755-001Apr 29, 2014RXYesYes➤ Try a Free Trial➤ Try a Free TrialYY
Takeda Pharms UsaACTOPLUS METmetformin hydrochloride; pioglitazone hydrochlorideTABLET;ORAL021842-002Aug 29, 2005ABRXYesYes➤ Try a Free Trial➤ Try a Free TrialY
Takeda Pharms UsaACTOPLUS METmetformin hydrochloride; pioglitazone hydrochlorideTABLET;ORAL021842-001Aug 29, 2005ABRXYesNo➤ Try a Free Trial➤ Try a Free TrialY
Celator PharmsVYXEOScytarabine; daunorubicin POWDER;IV (INFUSION)209401-001Aug 3, 2017RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
Sucampo Pharma LlcAMITIZAlubiprostoneCAPSULE;ORAL021908-001Jan 31, 2006RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
Celator PharmsVYXEOScytarabine; daunorubicin POWDER;IV (INFUSION)209401-001Aug 3, 2017RXYesYes➤ Try a Free Trial➤ Try a Free TrialYFOR THE TREATMENT OF ADULTS WITH NEWLY-DIAGNOSED THERAPY-RELATED ACUTE MYELOID LEUKEMIA (T-AML) OR AML WITH MYELODYSPLASIA-RELATED CHANGES (AML-MRC)
Sucampo Pharma LlcAMITIZAlubiprostoneCAPSULE;ORAL021908-002Apr 29, 2008RXYesNo➤ Try a Free Trial➤ Try a Free TrialY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Queensland Health
Healthtrust
Johnson and Johnson
Colorcon
Julphar
Boehringer Ingelheim
Chubb
QuintilesIMS
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot